In vitro activity of DQ-2556, a new cephalosporin.
AUTOR(ES)
Fujimoto, T
RESUMO
The in vitro antibacterial activity of DQ-2556, a new semisynthetic cephalosporin, was compared with that of ceftazidime and cefotaxime. The activity of DQ-2556 against members of the family Enterobacteriaceae was roughly comparable to that of cefotaxime. Against Pseudomonas aeruginosa, DQ-2556 was slightly less active than ceftazidime. DQ-2556 was more active than the reference cephalosporins against staphylococci. Haemophilus influenzae and Neisseria gonorrhoeae were also highly susceptible to DQ-2556.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=176491Documentos Relacionados
- Metabolic disposition of DQ-2556, a new cephalosporin, in rats, rabbits, dogs, and monkeys.
- In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
- In vitro activity of HR 810, a new cephalosporin.
- In vitro activity of ME1228, a new parenteral cephalosporin.
- In vitro activity of BMY-28100, a new oral cephalosporin.
